Blog

When to treat and when not to treat gastroesophageal reflux disease in infants

An important thing to consider!

This is the 4. out of 6 exciting presentations at the 2019 symposium may 27th. in copenhagen,

When to treat and when not to treat gastroesophageal reflux disease in infants

Presenter:
Dr. Maartje Singendonk, , postdoctoral fellow at the department of Pediatric Gastroenterology and Nutrition of the Emma Children’s Hospital, Amsterdam UMC, Holland

Abstract:
Historically, the focus of GERD treatment was on reducing acid burden, which resulted in a dramatic increase in prescription of proton pump inhibitors (PPIs). However, accumulating evidence shows PPIs to be ineffective in the reduction of GERD symptoms in infants. Furthermore, concerns regarding their safety and effects on the developing gut microbiome have recently been highlighted.
Current guidelines advice to be hesitant with treatment – but how do we manage patients in clinical practice? In this presentation the different treatment options for GERD symptoms in infants will be discussed as well as their limitations and potential side-effects.

More detalils and registration: www.lebahn.dk/symposium-2019/

Der er lukket for kommentarer.

Menu
Cookie- og privatlivspolitik